Extracellular polysaccharide-containing extract, exopolysaccharide and composition

Through specific extraction and purification steps, high-purity Bacillus thuringiensis extracellular polysaccharides are obtained, and combined with insecticidal crystal proteins, the insecticidal activity is significantly improved, and the problem of poor polysaccharide extraction in the existing technology is solved, and the problem of poor polysaccharide extraction effect is achieved. Effective prevention and control of fall armyworm and cotton bollworm.

CN118978610APending Publication Date: 2024-11-19INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI
View PDF 0 Cites 4 Cited by

Patent Information

Application Number
CN202411056357.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

In the prior art, the extracellular polysaccharides extracted from Bacillus thuringiensis have poor effect on insecticidal activity, and there are differences in the polysaccharide extraction methods of different strains, which affects the insecticidal effect.

Method used

High purity extracellular polysaccharides are obtained by specific extraction and purification steps including adjusting the pH of the fermentation broth, treatment with trichloroacetic acid and ethanol, centrifugal precipitation, protein removal, desalination, anion exchange chromatography and gel filtration chromatography, and high purity extracellular polysaccharides , and combine the insecticidal crystal protein Cry1Ac of Bacillus thuringiensis and the vegetative stage insecticidal protein Vip3Aa to form a composition.

Benefits of technology

The insecticidal activity of Bacillus thuringiensis crystal protein and vegetative stage insecticidal protein was significantly improved. In particular, the synergistic effect of the extracellular polysaccharide extracted from Bacillus thuringiensis G033A is much higher than that of other strains, and is effectively used to prevent and control grassland cravings. Moths and bollworms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978610A_ABST
    Figure CN118978610A_ABST
Patent Text Reader

Abstract

The invention relates to an extracellular polysaccharide-containing extract, extracellular polysaccharide and a composition, the extract is extracted from bacillus thuringiensis, the main component of the extract is extracellular polysaccharide, and the extracellular polysaccharide has a synergistic effect on bacillus thuringiensis insecticidal crystal protein and / or bacillus thuringiensis vegetative insecticidal protein.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biocides, and in particular to a polysaccharide having a synergistic effect on biocides. Background Art

[0002] Bacterial extracellular polysaccharides are a mixture of polysaccharides synthesized and secreted outside the cell by bacteria during their growth and metabolism. They are long-chain polymers formed by the polymerization of the same or different monosaccharide units through glycosidic bonds. Extracellular polysaccharides (EPSs) produced by bacteria mainly exist in two forms: capsular polysaccharides (CPS) tightly bound to the cell surface and slime polysaccharides ("Slime") secreted outside the cell in the form of mucus, also known as free extracellular polysaccharides (Free EPS). Among them, a small amount of free extracellular polysaccharides as a water-soluble matrix is ​​the main component of the biofilm. Using the tightness of the binding of extracellular polysaccharides to cells as a way to distinguish between capsular polysaccharides and free extracellular polysaccharides is not absolute. A small amount of capsular polysaccharides are unstable in connection with the phospholipids on the cell surface and can be released into the culture medium to become free extracellular polysaccharides. Free extracellular polysaccharides may become components of capsular polysaccharides due to their close contact with cells.

[0003] The presence of the outermost capsular polysaccharide of bacteria or the extracellular free polysaccharide results in an additional barrier between the cell membrane and the external environment. The diversity of the chemical composition of polysaccharides, such as the monosaccharide composition, leads to differences in the structure of different species of the same bacterial community, making their biological functions diverse. In addition, some physical and chemical properties of extracellular polysaccharides, such as stability, viscosity, flocculation, suspension, film-forming properties, and water-holding capacity, make them widely used in different industrial industries, such as the food industry, cosmetics industry, pharmaceutical industry, petroleum industry, mining industry, etc.

[0004] The composition, chemical and physical properties of bacterial extracellular polysaccharides determine the main conformation of polysaccharides, and these properties vary greatly depending on the type of bacteria. For example, bacterial flora of the same species can produce different types of capsular polysaccharides. Different biological functions are gradually being discovered. For example, under natural conditions, bacterial extracellular polysaccharides can be hidden on the surface of bacteria as an adhesive to interact with other bacterial surfaces or underlying substances, protect bacteria from external environmental stresses, serve as a matrix for bacteria to aggregate in the rhizosphere to form biofilms and maintain their stability, and can serve as signal molecules for bacteria to "communicate" with the outside world. In harsher growth environments, bacteria can use the exopolysaccharides they secrete as a carbon source.

[0005] The potential functions of bacterial exopolysaccharides remain to be explored. Summary of the invention

[0006] One aspect of the present invention provides an extract containing extracellular polysaccharides, which is obtained by the following steps: 1) adjusting the pH value of the fermentation broth of Bacillus thuringiensis G033A to 8 to 9, then performing a first centrifugation, and collecting a first supernatant after the first centrifugation; 2) adding trichloroacetic acid or an aqueous solution of trichloroacetic acid to the first supernatant, thereby treating the first supernatant with the trichloroacetic acid to obtain a first treated liquid, and then performing a second centrifugation to collect a second supernatant after the second centrifugation; 3) After adjusting the pH value of the second supernatant to 6 to 7, ethanol is added to the second supernatant to obtain a second treatment liquid, the second treatment liquid is precipitated, and then a third centrifugation is performed, and the precipitate after the third centrifugation is collected, and the precipitate is the wet extract containing extracellular polysaccharides.

[0007] In a specific embodiment, the precipitate is freeze-dried to obtain a dry extract containing exopolysaccharides.

[0008] In a specific embodiment, in step 2), the mass / volume content of the trichloroacetic acid and the first supernatant is 0.4% to 0.5%.

[0009] In a specific embodiment, in step 3), the volume of ethanol added to the second supernatant is 3 to 3.5 times the volume of the second supernatant.

[0010] In a specific embodiment, in step 2), the first treatment solution is placed at a temperature of 25 to 35° C. for 1.5 to 3 hours.

[0011] In a specific embodiment, in step 3), the second treatment solution is placed at 2 to 8° C. for 12 to 20 hours.

[0012] In a specific embodiment, the centrifugation speeds of the first centrifugation, the second centrifugation, and the third centrifugation are independently 6000 to 8000 r / min, the centrifugation temperatures are independently 3 to 10° C., and the centrifugation times are independently 30 to 40 min.

[0013] In a specific embodiment, the culture medium for culturing the Bacillus thuringiensis is one of LB culture medium, a sugar-producing culture medium with glucose as a substrate, and a sugar-producing culture medium with sucrose as a substrate.

[0014] In a specific embodiment, the precipitate is freeze-dried to obtain the extract.

[0015] The second aspect of the present invention provides an extracellular polysaccharide (i.e., pure extracellular polysaccharide), which is obtained by removing residual protein, desalting, purifying by anion exchange chromatography and gel filtration chromatography from the extract described in any one of the first aspect of the present invention.

[0016] In one embodiment, the steps of removing residual protein are as follows: (1) Quantify the residual protein in the sample using the BCA total protein quantification kit (Thermo); (2) Add proteinase K at a concentration of 1 / 10 of the total weight of residual protein; (3) Incubate the mixture in a 50°C water bath for 2 h and analyze by SDS-PAGE whether the protein has been completely removed. (4) If the residual protein is not completely removed, proteinase K needs to be added again for treatment until the protein is completely removed. After the protein is completely removed, the mixture is treated in a boiling water bath for 15 min to inactivate the protease and obtain a crude extracellular polysaccharide solution with the protein removed.

[0017] In one embodiment, the desalting step is as follows: (1) centrifuging the crude exopolysaccharide solution after deproteinization at 10,000 r / min for 20 min to remove impurities; (2) Place the desalting column HiPrep TM 26 / 10 Desalting Load into the protein purification system ÄKTA-25 and wash with ultrapure water including the desalting column HiPrep TM 26 / 10 Protein purification system ÄKTA-25 including desalting; (3) filtering the crude exopolysaccharide solution after protein removal through a 0.22 µm filter membrane to obtain a filtered crude exopolysaccharide solution, and loading 7 mL of the filtered crude exopolysaccharide solution onto a desalting column at a flow rate of 10 mL / min each time; (4) According to UV 490 The samples flowing out of the desalting column are collected starting and ending at the peak positions of the peak and the salt peak, respectively, to obtain a desalting chromatographic solution; (5) The phenol-sulfuric acid method was used to accurately detect the content of extracellular polysaccharides in the desalted chromatographic fluid, with a concentration of approximately 15 mg / mL.

[0018] In one embodiment, the steps of anion exchange chromatography are as follows: (1) installing an anion exchange chromatography column HiTrap Q HP Column (Q-HP) (e.g., a volume of 5 mL) in a protein purification system ÄKTA-25, washing the protein purification system ÄKTA-25 with ultrapure water, and balancing the anion exchange chromatography column with a 2.0 mol / L sodium chloride aqueous solution; (2) Based on the exopolysaccharide concentration in the desalted chromatographic solution determined by the phenol-sulfuric acid method (so that the concentration of exopolysaccharide is between 10 and 15 mg / mL), the desalted chromatographic solution was loaded onto the anion exchange chromatography column using the S1 loading pump of the protein purification system ÄKTA-25. The loading volume was 15 to 20 mL each time, and the flow rate was 2.0 mL / min. At the same time, the sample was manually collected using a 96-well deep-well plate at 1.7 mL / tube. (3) After the sample loading is completed, wash the anion exchange chromatography column with 5 column volumes of ultrapure water; (4) using a 2 mol / L sodium chloride aqueous solution for elution with a linear gradient from 0 to 100% for 20 min at a flow rate of 5 mL / min to obtain an eluate; (5) After the eluate is collected, the pores containing the eluate containing the extracellular polysaccharide are detected by the phenol-sulfuric acid method. If the result shows a single extracellular polysaccharide absorption peak, and the absorption peak appears when the salt ion concentration is between 5% and 10%, the eluates in the pores containing the extracellular polysaccharide are mixed and concentrated to 1 / 10 of the original volume (about 30 mL) using a freeze dryer to obtain an ion chromatography fluid.

[0019] In one embodiment, the steps of the gel filtration chromatography are as follows: (1) Install a gel filtration chromatography column HiLoad 26 / 600 Seperdex 200 prep grade column (Superdex200 prep grade, GE Healthcare Life Sciences) in the protein purification system ÄKTA-25, and clean the protein purification system ÄKTA-25 and the gel filtration chromatography column with 0.15 mol / L sodium chloride aqueous solution; (2) 5 mL of the ion chromatography solution was manually loaded onto the gel filtration chromatography column each time, and the sample was immediately collected. The system flow rate was 0.5 mL / min, and the sample was collected using a 96-well plate. 0.5 mL was collected from each well. After a total of 180 mL was collected, the collection was stopped to obtain the gel chromatography solution; (3) The pores containing the gel chromatographic solution of the exopolysaccharide are detected by the phenol-sulfuric acid method. If a single exopolysaccharide absorption peak is shown, the gel chromatographic solution of the pores containing the exopolysaccharide is mixed; if two or more exopolysaccharide absorption peaks are shown, the gel chromatographic solution of each pore is mixed according to the OD value. 490nmThe absorbance value is used to draw an elution curve. In order to ensure the purity of the sample, the wells at a single main peak are manually mixed, so that the gel chromatography fluid showing two or more absorption peaks is manually separated to obtain a purified single extracellular polysaccharide, which is freeze-dried into a powder or freeze-concentrated.

[0020] In a specific embodiment, the extracellular polysaccharide purified by gel filtration chromatography is finely purified again by Q-HP and HiLoad 26 / 600 Superdex200 prep grade. During the Q-HP purification, the system flow rate is reduced to 1 mL / min, and 0.5 mL is collected from each well. The phenol-sulfuric acid method test results show a lower absorption peak and a higher absorption peak, and the higher absorption peak is collected. Finally, the pure sugar of G033A extracellular polysaccharide is obtained by desalting and purification, and it is freeze-concentrated to a concentration of 25 mg / ml, or freeze-dried into powder.

[0021] In a specific embodiment, the weight average molecular weight of the extracellular polysaccharide is 71.484 kDa, the number average molecular weight of the extracellular polysaccharide is 66.625 kDa, the average molecular weight of the extracellular polysaccharide is 76.316 kDa, the polydispersity coefficient of the extracellular polysaccharide is 1.073, and the total sugar content of the extracellular polysaccharide is 100%, mannose is 78.52%, glucose is 12.19%, arabinose is 4.41%, glucuronic acid is 3.53%, and galactose is 1.34%.

[0022] The third aspect of the present invention provides a composition, which comprises the extract as described in any one of the first aspect of the present invention or the extracellular polysaccharide as described in the second aspect of the present invention, and an active component, wherein the active component is the insecticidal crystal protein Cry1Ac derived from Bacillus thuringiensis and / or the vegetative insecticidal protein Vip3Aa derived from Bacillus thuringiensis.

[0023] In a specific embodiment, the amino acid sequence of the insecticidal crystal protein is shown in GenBank: AY730621.1; the amino acid sequence of the vegetative insecticidal protein is shown in GenBank: AAR36859.1.

[0024] In a specific embodiment, the active component is the G033A strain, wherein the G033A strain contains genes encoding multiple insecticidal crystal proteins such as Cry1Ac and Cry3Aa, as well as a gene encoding Vip3Aa protein.

[0025] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the insecticidal crystal protein to the exopolysaccharide is 1:(40 to 160).

[0026] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the insecticidal crystal protein to the exopolysaccharide is 1:(80 to 160).

[0027] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the insecticidal crystal protein to the exopolysaccharide is 1:(40 to 80).

[0028] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the vegetative insecticidal protein to the exopolysaccharide is 1:(1250 to 5000).

[0029] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the vegetative insecticidal protein to the exopolysaccharide is 1:(1250 to 2500).

[0030] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the vegetative insecticidal protein to the exopolysaccharide is 1:(2500 to 5000).

[0031] In a specific embodiment, the G033A strain is in the form of a wettable powder.

[0032] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the wettable powder of the G033A strain to the exopolysaccharide is 1:(20 to 320).

[0033] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the wettable powder of the G033A strain to the exopolysaccharide is 1:(20 to 160).

[0034] In a specific embodiment, based on the phenol-sulfuric acid method to quantify the exopolysaccharide in the extract or the exopolysaccharide as described in the second embodiment of the present invention, the mass ratio of the wettable powder of the G033A strain to the exopolysaccharide is 1:(80 to 320).

[0035] The fourth aspect of the present invention provides the use of the extract as described in any one of the first aspect of the present invention, the extracellular polysaccharide as described in the second aspect of the present invention, or the composition as described in any one of the third aspect of the present invention for controlling fall armyworm and / or cotton bollworm.

[0036] Beneficial effects of the present invention: The present invention finds that the extract containing extracellular polysaccharides extracted from Bacillus thuringiensis G033A (i.e., crude extracellular polysaccharides) can produce a synergistic effect on the insecticidal activity of Bacillus thuringiensis insecticidal crystal protein or Bacillus thuringiensis vegetative stage insecticidal protein, and its synergistic effect is much higher than the synergistic effect of the extract containing extracellular polysaccharides extracted from Bacillus thuringiensis 4D19. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] Figure 1 The GPC-RI-MALS chromatogram is shown, the black line represents the changing trend of the molar mass of EPS-G033A with the retention time, the red line represents the changing trend of the LS of EPS-G033A with the retention time, and the blue line represents the changing trend of the RI of EPS-G033A with the retention time.

[0038] Figure 2 The liquid chromatography results of the mixed standard monosaccharides are shown. Among them, Fuc is trehalose, Rha is rhamnose, Ara is arabinose, Gal is galactose, Glc is glucose, Xyl is xylose, Man is mannose, Fru is fructose, Rib is ribose, Gal-UA is galacturonic acid, Gul-UA is guluronic acid, Glc-UA is glucuronic acid, and Man-UA is mannuronic acid.

[0039] Figure 3 The liquid chromatography results of the monosaccharide composition of EPS-G033A pure sugar are shown, where Ara is arabinose, Gal is galactose, Glc is glucose, Man is mannose, and Glc-UA is glucuronic acid.

[0040] Figure 4 Artificial diet formulations are shown.

[0041] Figure 5 The effect of crude exopolysaccharide on the insecticidal activity of Cry1Ac crystal protein against Spodoptera frugiperda was shown.

[0042] Figure 6 The effects of crude exopolysaccharides of G033A and 4D19 on the insecticidal activity of Vip3Aa11 against Spodoptera frugiperda were shown.

[0043] Figure 7The results show the effects of crude extracellular polysaccharides of G033A, BiotPS3 and BiotP4 on the insecticidal activity of Vip3Aa11 against fall armyworm. *** indicates that the difference between treatments was not statistically significant in the one-way ANOVA analysis. p The difference was significant at the <0.001 level.

[0044] Figure 8 The insecticidal activity analysis of Example 7 is shown. Among them, ** indicates that the treatments were p The difference was significant at the <0.01 level.

[0045] Fig. 9 The insecticidal activity analysis of Example 8 is shown. Among them, ** indicates that the treatments were p The difference was significant at the <0.01 level.

[0046] Fig.10 The insecticidal activity analysis of Example 9 is shown. Wherein, * indicates that the treatments were p <0.05 level; ** indicates that the treatments p <0.01 level; *** indicates that the treatments were significantly different in the one-way ANOVA analysis. p The difference was significant at the <0.001 level.

[0047] Fig.11 The insecticidal activity analysis of Example 10 is shown. Wherein, * indicates that the treatments were p <0.05 level; *** indicates that the treatments p The difference was significant at the <0.001 level. DETAILED DESCRIPTION

[0048] The above contents of the present invention are further described in detail below in the form of preferred implementation cases, but they do not constitute a limitation to the present invention.

[0049] Unless otherwise specified, the reagents in the embodiments of the present invention can be purchased through commercial channels.

[0050] Peptone and yeast extract were purchased from Beijing Bingda Biotechnology Co., Ltd.

[0051] Glucose, sucrose and aniline blue were purchased from Sigma.

[0052] Other biochemical reagents were commercially available domestically or imported analytically pure or electrophoresis pure chemical reagents.

[0053] Liquid LB medium: 10.0 g peptone, 5.0 g yeast extract, 10.0 g sodium chloride, dilute to 1.0 L with distilled water, 121°C for 20 min.

[0054] Sugar production medium with glucose as substrate: 10.0 g glucose, 5.0 g yeast extract, dilute to 1.0 L with distilled water, 115°C for 30 min.

[0055] Sugar production medium with sucrose as substrate: 20.0 g sucrose, 5.0 g yeast extract, dilute to 1.0 L with distilled water, 115°C for 30 min.

[0056] Aniline blue selective culture medium: Add 0.05 g / L of aniline blue solid and 15.0 g / L of agar powder to the above two sugar-producing culture media, respectively.

[0057] The reagents for extracellular polysaccharide extraction and quantification are as follows. 1 mol / L sodium hydroxide: 4.0 g sodium hydroxide is dissolved in 100 mL sterile distilled water and stored at room temperature. 2 mol / L hydrochloric acid: 500 mL sterile distilled water is added to 100 mL concentrated hydrochloric acid and stored at room temperature. 95% ethanol: 50 mL sterile distilled water is added to 950 mL anhydrous ethanol and stored at room temperature. 80% phenol: 80.0 g phenol is dissolved in 50 mL sterile distilled water and diluted to 100 mL with sterile distilled water, and stored at 4°C in the dark.

[0058] Main instruments and equipment: Fully automatic moist heat sterilizer, SANYO, Japan, model MLS-3780 / MAC 350P; clean bench, Beijing Hadonglian Company, model DL-CJ-2N; constant temperature incubator, Shanghai Experimental Instrument Factory, model DHP120; temperature-controlled shaker, Thermo, USA, model MAXQ5000; desktop centrifuge, Eppenddorf, Germany, model 5415C; high-speed centrifuge, Beckman, USA, model Avanti J-26xp; freeze dryer VirTis, USA.

[0059] The G033A strain was purchased from Wuhan Kono Biotechnology Co., Ltd.; the 4D19 standard strain was from the Bacillus Collection Center of Ohio State University, USA. Bacillus The strain BiotPS3 was deposited in the General Microbiology Center of China Microorganism Culture Collection Committee with the deposit number CGMCC No. 20588 on September 2, 2020 at the Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing. It is systematically classified as Bacillus thuringiensis ( Bacillus thuringiensis); BiotP4 strain is deposited in the General Microbiology Center of China Microbiological Culture Collection Committee, with the deposit number CGMCC No. 24550, the deposit date is March 21, 2022, and the deposit address is: Institute of Microbiology, Chinese Academy of Sciences, No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing. Its systematic classification is Bacillus thuringiensis ( Bacillus thuringiensis ).

[0060] Example 1: Extraction and quantification of crude exopolysaccharides.

[0061] 1.1 Extraction of crude exopolysaccharides (i.e., exopolysaccharide extracts).

[0062] (1) Take 10 µL of glycerol culture of Bacillus thuringiensis G033A and inoculate it into 5 mL of liquid LB medium. Incubate at 30°C and 220 rpm for 10 h to obtain activated bacterial solution.

[0063] (2) Transfer the activated bacterial solution at a 1% inoculum size into 100 mL of liquid LB medium, sugar-producing medium with glucose as the substrate, or sugar-producing medium with sucrose as the substrate, and culture in a 500 mL Erlenmeyer flask for 30 h.

[0064] (3) Collect the bacterial cultures obtained in the three culture media respectively, adjust the pH of the bacterial cultures to 8.5 with 1 mol / L NaOH, centrifuge at 4°C, 7000 r / min for 30 min, and collect the first supernatant.

[0065] (4) Add 1 / 10 volume of 5 wt% trichloroacetic acid aqueous solution to the first supernatant and denature the protein at 25°C for 2 hours.

[0066] (5) Centrifuge at 4°C, 7000 r / min for 30 min, collect the second supernatant, and adjust the pH to 6.5.

[0067] (6) Add 3 times the volume of anhydrous ethanol and precipitate in a refrigerator at 4°C for 12 hours.

[0068] (7) Centrifuge at 4°C, 7000 r / min for 30 min, discard the supernatant, and freeze-dry the precipitate to obtain crude extracellular polysaccharide powder.

[0069] 1.2 Quantification of extracellular polysaccharides.

[0070] 1.2.1 Preparation of standard curve.

[0071] First, prepare the glucose mother solution: take 0.1 g of glucose and dissolve it in 250 mL of sterile distilled water and stir evenly to obtain the glucose mother solution.

[0072] Then, glucose mother solution was used to prepare glucose standard solutions with different concentration gradients, and then 0.1 mL of 98% concentrated sulfuric acid and 0.5 mL of 6wt% phenol aqueous solution were added to the glucose standard solutions with different concentration gradients, and sterile distilled water was added to 0.8 mL system. Slowly mix, cool, stand at room temperature for 20 minutes, take 200µL to the ELISA plate and measure its absorbance at 490 nm, and use sterile distilled water instead of the sample as a blank control. Three replicates were set for each treatment group to draw a standard curve.

[0073] 1.2.2 Quantification by phenol-sulfuric acid method.

[0074] According to the amount of extract, dilute the extract in different gradients (to make OD 490nm The exopolysaccharide aqueous solution (value between 0.2 and 1.0) was placed in a centrifuge tube, 0.1 mL of concentrated sulfuric acid and 0.5 mL of 6wt% phenol aqueous solution were added, and then the system was supplemented to 0.8 mL with sterile distilled water, mixed evenly, cooled, and allowed to stand at room temperature for 20 min. 200 μL was taken to measure its absorbance at 490 nm in an ELISA plate, and the exopolysaccharide content in the extract was calculated according to the standard curve drawn in 1.2.1. Among them, the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in liquid LB medium was 91 g / L bacterial liquid; the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in a sugar-producing medium with glucose as the substrate was 85 g / L bacterial liquid; the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in a sugar-producing medium with sucrose as the substrate was 98 g / L bacterial liquid.

[0075] Example 2: Extraction and quantification of crude exopolysaccharides.

[0076] The crude exopolysaccharide extraction was the same as in Section 1.1 of Example 1, except that: In step (2), the activated bacterial solution was transferred to 100 mL of liquid LB medium and liquid sugar production medium with sucrose as substrate at a 1% inoculation rate, and cultured in a 500 mL Erlenmeyer flask for 30 h; In step (3), the bacterial liquids cultured in the three culture media were collected respectively, the pH of the bacterial liquids was adjusted to 8 with 1 mol / L NaOH, and the mixture was centrifuged at 3°C ​​and 6000 r / min for 40 min to collect the first supernatant; In step (4), 1 / 10 volume of 4 wt% trichloroacetic acid aqueous solution is added to the first supernatant, and the protein is denatured at 35° C. for 3 hours; In step (5), centrifuge at 3°C, 8000 r / min for 30 min, collect the second supernatant, and adjust the pH to 6; In step (6), add 3 volumes of anhydrous ethanol and precipitate in a refrigerator at 2°C for 16 hours; In step (7), centrifuge at 3°C, 6000 r / min for 40 min, discard the supernatant, and freeze-dry the precipitate to obtain crude extracellular polysaccharide powder.

[0077] After quantification, the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in liquid LB medium was 90 g / L of bacterial liquid; the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in a sugar-producing medium with glucose as a substrate was 84 g / L of bacterial liquid; the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in a sugar-producing medium with sucrose as a substrate was 96 g / L of bacterial liquid.

[0078] Example 3: Extraction and quantification of crude exopolysaccharides.

[0079] The crude exopolysaccharide extraction was the same as in Section 1.1 of Example 1, except that: In step (3), the bacterial liquid obtained by culturing in the three culture media was collected respectively, and the pH of the bacterial liquid was adjusted to 9 with 1 mol / L NaOH, and the mixture was centrifuged at 8000 r / min for 30 min at 10°C to collect the first supernatant; In step (4), 1 / 10 volume of 5 wt% trichloroacetic acid aqueous solution is added to the first supernatant, and the protein is denatured at 25° C. for 1.5 hours; In step (5), centrifuge at 3°C, 6000 r / min for 40 min, collect the second supernatant, and adjust the pH to 7; In step (6), add 3 times the volume of anhydrous ethanol and precipitate in a refrigerator at 8°C for 20 hours; In step (7), centrifuge at 10°C, 8000 r / min for 30 min, discard the supernatant, and freeze-dry the precipitate to obtain crude extracellular polysaccharide powder.

[0080] After quantification, the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in liquid LB medium was 90 g / L of bacterial liquid; the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in a sugar-producing medium with glucose as a substrate was 85 g / L of bacterial liquid; the amount of exopolysaccharide in the crude exopolysaccharide extracted from the G033A strain cultured in a sugar-producing medium with sucrose as a substrate was 95 g / L of bacterial liquid.

[0081] Example 4: Purification of extracellular polysaccharides.

[0082] Exopolysaccharides were extracted from the bacterial solution obtained by culturing the G033A standard strain in 7 L LB medium.

[0083] The extraction and quantification of crude exopolysaccharide were the same as in Example 1, and then the crude exopolysaccharide powder was dissolved in 50 mL ultrapure water.

[0084] 1. Purification of extracellular polysaccharides.

[0085] 1.1 Digestion of residual protein.

[0086] (1) The residual protein in the sample was quantified using the BCA total protein quantification kit (Thermo).

[0087] (2) Add proteinase K at a concentration of 1 / 10 of the total weight of residual protein.

[0088] (3) Incubate the mixture in a 50°C water bath for 2 h and analyze by SDS-PAGE whether the protein has been completely removed.

[0089] (4) If the residual protein is not completely removed, proteinase K needs to be added again for treatment until the protein is completely removed. After the protein is completely removed, the solution is treated in a boiling water bath for 15 min to inactivate the protease and obtain a crude extracellular polysaccharide solution with the protein removed for later purification.

[0090] 1.2 Desalination.

[0091] The desalting column used was HiPrep TM 26 / 10 Desalting, the purification process of the deproteinized crude exopolysaccharide solution is as follows: (1) Centrifuge the crude exopolysaccharide solution after protein removal at 10,000 r / min for 20 min to remove impurities; (2) Place the desalting column HiPrep TM 26 / 10 Desalting Load into the protein purification system ÄKTA-25 and wash with ultrapure water including the desalting column HiPrep TM 26 / 10 Protein purification system ÄKTA-25 including desalting; (3) Filter the crude exopolysaccharide solution after removing the protein with a 0.22 µm filter membrane to obtain the filtered crude exopolysaccharide solution. Take 7 mL of the filtered crude exopolysaccharide solution each time and load it onto the desalting column at a flow rate of 10 mL / min; (4) According to UV 490 The samples flowing out of the desalting column are collected starting and ending at the peak positions of the peak and the salt peak, respectively, to obtain a desalting chromatographic solution; (5) Finally, the protein purification system ÄKTA-25 and the desalting column HiPrep were cleaned with ultrapure water and 20% (v / v) ethanol. TM 26 / 10 Desalting; (6) The phenol-sulfuric acid method was used to accurately detect the content of extracellular polysaccharides in the desalted chromatographic fluid, with a concentration of approximately 15 mg / mL.

[0092] 1.3 Ion exchange chromatography.

[0093] The anion exchange chromatography column used was a 5 mL HiTrap Q HP Column (Q-HP), and the purification process of the desalted chromatographic solution was as follows: (1) Installing the anion exchange chromatography column Q-HP in the protein purification system ÄKTA-25, cleaning the protein purification system ÄKTA-25 with ultrapure water, and balancing the anion exchange chromatography column Q-HP with a 2.0 mol / L sodium chloride aqueous solution; (2) Based on the concentration of extracellular polysaccharides in the desalted chromatographic solution determined by the phenol-sulfuric acid method (the concentration was between 10 and 15 mg / mL), the desalted chromatographic solution was loaded onto the anion exchange chromatography column Q-HP using the S1 loading pump of the protein purification system ÄKTA-25. The loading volume was 15 to 20 mL each time, and the flow rate was 2.0 mL / min. At the same time, the sample was manually collected using a 96-well deep-well plate at 1.7 mL / tube. (3) After the sample loading is completed, wash the anion exchange chromatography column Q-HP with 5 column volumes of ultrapure water; (4) using a 2 mol / L sodium chloride aqueous solution for elution with a linear gradient from 0 to 100% for 20 min at a flow rate of 5 mL / min to obtain an eluate; (5) Finally, the protein purification system ÄKTA-25 and the anion exchange chromatography column Q-HP were cleaned with ultrapure water and 20% ethanol respectively; (6) After the collection is completed, the pores containing the eluate containing the extracellular polysaccharide are detected by the phenol-sulfuric acid method. The results show a single polysaccharide absorption peak, and the absorption peak appears when the salt ion concentration is between 5% and 10%. The eluates from the pores containing the extracellular polysaccharide are mixed and concentrated to 1 / 10 of the original volume (about 30 mL) using a freeze dryer to obtain an ion chromatography fluid.

[0094] 1.4 Gel filtration chromatography.

[0095] The gel filtration chromatography column used was HiLoad 26 / 600 Seperdex 200 prep grade column (Superdex200 prep grade, GE Healthcare Life Sciences). The purification process of the ion chromatography fluid was as follows: (1) Install the gel filtration chromatography column HiLoad 26 / 600 Seperdex 200 prep grade column in the protein purification system ÄKTA-25, and clean the protein purification system ÄKTA-25 and the gel filtration chromatography column with 0.15 mol / L sodium chloride aqueous solution; (2) Take 5 mL of ion chromatography fluid each time and manually load it onto the gel filtration chromatography column, and immediately start collecting samples. The system flow rate is 0.5 mL / min, and a 96-well plate is used for collection. 0.5 mL is collected from each well. After a total of 180 mL is collected, stop collecting to obtain the gel chromatography fluid. (3) Finally, the protein purification system and gel filtration column were cleaned with ultrapure water and 20% ethanol respectively; (4) The pores containing the gel chromatographic solution of the extracellular polysaccharide were detected by the phenol-sulfuric acid method. The results showed a single absorption peak of the extracellular polysaccharide. The gel chromatographic solution of each pore was divided into 490nm The absorbance value was used to draw the elution curve, and the eluate at the pore position corresponding to the absorption peak was collected to obtain EPS-G033A gel chromatography sugar. The EPS- sample was freeze-concentrated to 1 / 10 of the original volume.

[0096] In order to further ensure the purity of the sample, the above EPS-samples were finely purified again using Q-HP and HiLoad 26 / 600 Superdex200 prep grade. During Q-HP purification, the system flow rate was reduced to 1 mL / min, and 0.5 mL was collected from each well. The phenol-sulfuric acid method showed a lower absorption peak and a higher absorption peak, and the higher absorption peak was collected. Finally, the pure sugar of G033A extracellular polysaccharide (hereinafter referred to as EPS-G033A pure sugar) was obtained by desalting and purification, and it was freeze-concentrated to a concentration of 25 mg / ml, or freeze-dried into powder.

[0097] 2. Analysis of the physicochemical properties of extracellular polysaccharides.

[0098] GPC-RI-MALS was used to determine the weight average molecular weight (Mw), number average molecular weight (Mn) and Z average molecular weight (Mz) of the ESP-G033A extracellular polysaccharide of the present invention. Figure 1 The result is obtained.

[0099] The Mw, Mn and Mz of the ESP-G033A extracellular polysaccharide are 71.484, 66.625 and 76.316 kDa, respectively, and the polydispersity coefficient (Mw / Mn) is 1.073. Among them, the polydispersity coefficient (Mw / Mn) is a key parameter for measuring the molecular weight distribution range of the polymer, and its value can directly reflect the width of the molecular weight distribution. When the polydispersity coefficient is large, it indicates that there are more molecules of different molecular weights in the polymer, and the closer the coefficient is to 1, the more concentrated the molecular weight distribution is. The polydispersity coefficient (Mw / Mn) of the extracellular polysaccharide of the present invention is 1.073, indicating that the molecular weight distribution is relatively concentrated.

[0100] 3. Analysis of monosaccharide composition.

[0101] The monosaccharide composition analysis was performed using a Thermo ion exchange chromatography system (High-performance anion-exchange chromatography, model ICS5000+, USA), and the liquid chromatography column was Dionex™ CarboPac™ PA10 (250*4.0mm, 10µm). The specific experimental process is as follows: (1) Preparation of standards: Weigh 100 mg of different monosaccharide standards and dissolve them in 10 mL of ultrapure water. The monosaccharide standards used include trehalose, rhamnose, arabinose, galactose, glucose, xylose, mannose, fructose, ribose, galacturonic acid, guluronic acid, glucuronic acid, and mannuronic acid. (2) Drawing of standard curve: dilute the above standards into 1, 10, 20, 30, 40, and 50 µg / mL aqueous solutions, respectively, with a sample volume of 20 µL. Mobile phase A is water, mobile phase B is 100 mM NaOH, and the column temperature is maintained at 30°C. Draw a curve based on the retention time and peak height of each component in the system. (3) Weigh 5 mg (± 0.05 mg) of EPS-G033A pure sugar powder that has been subjected to gel filtration chromatography and freeze-dried, add trifluoroacetic acid and hydrolyze at 121°C for 2 h, blow dry with nitrogen, then wash with methanol and blow dry again, repeat methanol washing and blowing dry 2 to 3 times. Add sterile water to dissolve the test; (4) Compare the retention time of pure sugar EPS-G033A with that of standard monosaccharide samples to determine the monosaccharide composition of pure sugar EPS-G033A.

[0102] The analysis of the monosaccharide composition of EPS-G033A pure sugar was performed using a Thermo ICS5000+ ion chromatography system (ICS5000+, Thermo Fisher Scientific, USA), a Dionex™ CarboPac™ PA10 (250*4.0mm, 10 μm) liquid chromatography column, and an injection volume of 20 μL. The mobile phase was A (H2O), the mobile phase was B (100 mM NaOH), the column temperature was 30°C, and the electrochemical detector was used to analyze and detect the monosaccharide components. The results are shown in Figure 2 and Figure 3 As shown, Figure 2 The chromatographic results of 15 mixed standard monosaccharides are shown in Figure 2. Figure 3 The chromatographic results of EPS-G033A pure sugar are Figure 3 The retention time of each component in EPS-G033A pure sugar is Figure 2 By comparing the retention time of the standard sample, it was found that the monosaccharide components of EPS-G033A pure sugar were mainly mannose (78.52%), glucose (12.19%), arabinose (4.41%), glucuronic acid (3.53%), and galactose (1.34%), indicating that it is a heteropolysaccharide containing 5 monosaccharides.

[0103] Example 5: Bioassay activity analysis.

[0104] The preparation method of the crude exopolysaccharide concentrate of the G033A strain or the 4D19 strain is the same as that in Section 1.1 of Example 1, wherein the medium used is liquid LB medium. The quantification of the crude exopolysaccharide concentrate is the same as that in Section 1.2 of Example 1.

[0105] 1. Extraction and purification of Cry1Ac protein toxin.

[0106] The HD73 strain contains only one insecticidal crystal protein, Cry1Ac. The GenBank address of the Cry1Ac insecticidal crystal protein is AY730621.1.

[0107] The detailed extraction method refers to the repeated crystal pyrolysis method reported by ZHOU et al. (2015): (1) Take 10 µL of Bt HD73 glycerol culture and streak it on LB solid medium plate and activate it at 30°C overnight; (2) Pick a single activated colony and culture it in liquid LB medium at 30°C and 220 rpm for 12 h; (3) Transfer the culture to 300 mL 1 / 2 LB medium (1.0 L conical flask) at a ratio of 1% and culture at 30°C and 220 rpm until the cells are more than half lysed. (4) 4°C, 8000 × g Centrifuge for 10 min and collect the precipitate; (5) After washing the precipitate with a pre-cooled 1 mol / L sodium chloride aqueous solution, wash it 2 to 3 times with pre-cooled sterile water. During the washing process, mix it thoroughly; (6) Add an appropriate amount of crystal protein lysis buffer (20 to 30 mL / 1 L bacterial solution) to the washed precipitate, mix thoroughly, and shake horizontally on ice for 1 h. (7) 4°C, 13000 × g The precipitate and supernatant were collected by centrifugation for 10 min; (8) Add an appropriate amount of crystal protein lysis buffer to the precipitate and repeat the lysis for 1 h. Centrifuge and collect the supernatant. (9) Add 4 mol / L NaAc-HAc to the supernatant after the two lysis to a pH of 4.5-5.0 (approximately 1 / 7 of the supernatant volume) and precipitate at 4°C overnight; (10) 4°C, 13000 × g Collect the precipitate by centrifugation for 15 min, and wash the precipitate 2 to 3 times with pre-cooled sterile water. Stir evenly during each washing process to thoroughly wash the NaAc-HAc in the precipitate. (11) Add 20 mM Na2CO3 / NaHCO3 aqueous solution to the precipitate to fully dissolve the crystal protein, obtain the crystal protein protoxin solution, and detect it by SDS-PAGE; (12) Wash the protein purification system ÄKTA-25 and the desalting column HiPrep with buffer TM 26 / 10 Desalting; (13) Load 7 mL of crystal protein protoxin solution at a flow rate of 10 mL / min; (14) According to UV 280 Peaks are displayed and samples are collected manually; (15) After sample collection, the protein purification system ÄKTA-25 and the desalting column HiPrep were cleaned with ultrapure water and 20% ethanol, respectively. TM 26 / 10 Desalting; (16) SDS-PAGE detection of UV 280 Samples collected below the peak are shown and quantified with BSA.

[0108] 2. Preparation of biological activity test solution.

[0109] The G033A crude extracellular polysaccharide concentrate was prepared with distilled water into a biological activity test solution 1# with a final concentration of 10 mg / mL to perform a biological activity assay on the fall armyworm.

[0110] The 4D19 crude extracellular polysaccharide concentrate was prepared with distilled water into a biological activity test solution 2# with a final concentration of 10 mg / mL to perform biological activity assay on fall armyworm.

[0111] Cry1Ac crystal protein protoxin was prepared into a bioactive test solution 3# with a final concentration of 250 µg / mL using 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) for bioactivity assay against fall armyworm.

[0112] The bioactivity test solution 4# was prepared with 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) with a final concentration of 250 µg / mL of Cry1Ac crystal protein protoxin and a final concentration of 10 mg / mL of G033A crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0113] The bioactivity test solution 5# was prepared with 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) with a final concentration of 250 µg / mL of Cry1Ac crystal protein protoxin and a final concentration of 10 mg / mL of 4D19 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0114] Cry1Ac crystal protein protoxin was prepared into a bioactive test solution 6# with a final concentration of 125 µg / mL using 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) for bioactivity assay against fall armyworm.

[0115] The bioactivity test solution 7# was prepared with 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) with a final concentration of 125 µg / mL of Cry1Ac crystal protein protoxin and a final concentration of 10 mg / mL of G033A crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0116] The bioactivity test solution 8# was prepared with 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) with a final concentration of 125 µg / mL of Cry1Ac crystal protein protoxin and a final concentration of 10 mg / mL of 4D19 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0117] Cry1Ac crystal protein protoxin was prepared into a bioactive test solution 9# with a final concentration of 62.5 µg / mL using 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) for bioactivity assay against fall armyworm.

[0118] The biological activity test solution 10# was prepared with 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) with a final concentration of Cry1Ac crystal protein protoxin of 62.5 µg / mL and a final concentration of G033A crude extracellular polysaccharide of 10 mg / mL to carry out biological activity determination against fall armyworm.

[0119] The bioactivity test solution 11# was prepared with 20 mM Na2CO3-NaHCO3 aqueous solution (pH 9.8) with a final concentration of 62.5 µg / mL of Cry1Ac crystal protein protoxin and a final concentration of 10 mg / mL of 4D19 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0120] A 20 mM Na2CO3 / NaHCO3 aqueous solution was used as blank test solution 12#.

[0121] The steps of the bioactivity assay for fall armyworm are as follows: (1) Weigh 15 g of artificial feed ( Figure 4 ) Place the feed in a sterile culture dish, wear gloves and press the feed until there are no lumps or particles, and spread it evenly in the dish; (2) Use a pipette to draw up 3 mL of the prepared bioactive test solution or blank test solution and blow it evenly onto the surface of the feed. Use gloved hands to knead the feed repeatedly to mix it evenly and then place it at room temperature for 1 to 2 hours to allow excess water in the feed to evaporate. (3) Use a medicine spoon to evenly distribute the feed into a sterilized and dried 24-well culture plate, with the feed facing one side; (4) Use a brush to pick up silk threads and place newly hatched larvae of Fall Armyworm in a 24-well culture plate, one end in each well; (5) Place the 24-well culture plate in an insect culture room at a temperature of (27±1)°C, RH of (65±5)%, and a photoperiod of 16L:8D, with 3 replicates for each concentration; (6) After 7 days, count the number of dead and live worms and calculate the average mortality rate and adjusted mortality rate.

[0122] Results Figure 5 The results showed that the crude exopolysaccharides secreted by the G033A strain and the crude exopolysaccharides secreted by the 4D19 strain were non-toxic to the fall armyworm, but the crude exopolysaccharides secreted by the G033A strain and the crude exopolysaccharides secreted by the 4D19 strain could significantly increase the insecticidal activity of Cry1Ac crystal protein toxin against the fall armyworm, among which the crude exopolysaccharides secreted by the G033A strain increased the insecticidal activity of Cry1Ac against the fall armyworm more.

[0123] Example 6: Bioassay activity analysis.

[0124] The preparation method of crude exopolysaccharide concentrate of G033A strain, 4D19 strain, BiotPS3 strain and BiotP4 strain is the same as that in Section 1.1 of Example 1, wherein the medium used is liquid LB medium. The quantification of crude exopolysaccharide concentrate is the same as that in Section 1.2 of Example 1.

[0125] 1. Expression and quantification of Vip3Aa11 protein.

[0126] The nucleotides of the expression frame in the genbank accession number AY489126.1 were synthesized by Sangon Biotech (Shanghai) Co., Ltd. The nucleotides in the genbank accession number AY489126.1 encode the protein in the genbank accession number AAR36859.1 (i.e., Vip3Aa11 protein).

[0127] The nucleotide sequence shown in AY489126.1 was connected to the pET28a vector to obtain the pET-VIP recombinant plasmid, and then the positive recombinant plasmid was transformed into Escherichia coli BL21 (DE3), and the positive transformant BL21 (DE3) / pET-VIP was screened.

[0128] Pick a fresh colony of BL21 (DE3) / pET-VIP and inoculate it into 5 ml of LB liquid medium for 8 hours. Then inoculate it into a fermenter containing 20 L of sterilized LB medium (with 1 / 1000 ampicillin) at 1% inoculum and culture at 37°C, 220 rpm for about 3.5 h until OD 600 nm When the concentration of IPTG was 0.6, IPTG was added to a final concentration of 0.5 mmol / L, the induction temperature was set at 20°C, the induction culture was carried out for 12 h, and then the induced bacteria were collected by centrifugation at 10000 g for 15 min at 4°C, and the bacteria were evenly suspended in 20 mmol / L Tris-HCl (pH 8.0). Next, the bacteria were ultrasonically disrupted at 70% power for 6 min (3 s supersonic and 5 s stop), and then centrifuged at 4°C and 10000 g for 25 min, and the supernatant and precipitate were collected respectively, among which the precipitate was suspended in 20 mmol / L Tris-HCl (pH 8.0). The supernatant and the suspended precipitate were detected by SDS-PAGE, and the results showed that the expression level of Vip protein in the supernatant (soluble component) was more than double that in the precipitate (insoluble component), so the insecticidal activity analysis was carried out with the soluble component.

[0129] Before the activity assay, the concentration of Vip protein was quantified by BSA.

[0130] 2. Preparation of the first set of biological activity test solutions.

[0131] The G033A crude extracellular polysaccharide concentrate was prepared with distilled water into a biological activity test solution 13# with a final concentration of 10 mg / mL to perform biological activity assay on fall armyworm.

[0132] The 4D19 crude extracellular polysaccharide concentrate was prepared with distilled water into a biological activity test solution 14# with a final concentration of 10 mg / mL to perform biological activity assay on fall armyworm.

[0133] Vip3Aa11 was prepared into a bioactive test solution 15# with a final concentration of 4 µg / mL using 20 mM Tris-HCl aqueous solution (pH 8.0) for bioactivity assay against Spodoptera frugiperda.

[0134] The bioactivity test solution 16# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 10 mg / mL for G033A crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0135] The bioactivity test solution 17# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 5 mg / mL for G033A crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0136] The bioactivity test solution 18# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 2.5 mg / mL for G033A crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0137] The bioactivity test solution 19# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and a final concentration of 10 mg / mL for 4D19 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0138] The bioactivity test solution 20# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 5 mg / mL for 4D19 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0139] The bioactivity test solution 21# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and a final concentration of 2.5 mg / mL for 4D19 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0140] Vip3Aa11 was prepared into a bioactive test solution 22# with a final concentration of 2 µg / mL using 20 mM Tris-HCl aqueous solution (pH 8.0) for bioactivity assay against Spodoptera frugiperda.

[0141] The bioactivity test solution 23# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 2 µg / mL for Vip3Aa11 and 5 mg / mL for G033A crude exopolysaccharide to carry out bioactivity assay against fall armyworm.

[0142] The bioactivity test solution 24# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 2 µg / mL for Vip3Aa11 and 2.5 mg / mL for G033A crude exopolysaccharide to carry out bioactivity assay against fall armyworm.

[0143] The bioactivity test solution 25# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 2 µg / mL for Vip3Aa11 and 5 mg / mL for 4D19 crude exopolysaccharide to carry out bioactivity assay against fall armyworm.

[0144] The bioactivity test solution 26# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 2 µg / mL for Vip3Aa11 and 2.5 mg / mL for 4D19 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0145] A 20 mM Tris-HCl aqueous solution (pH 8.0) was used as blank test solution 27#.

[0146] The biological activity assay procedure for fall armyworm was the same as in Example 5, and the results are shown in Figure 6 The results showed that the crude exopolysaccharides secreted by the G033A strain and the crude exopolysaccharides secreted by the 4D19 strain were non-toxic to the fall armyworm, but the crude exopolysaccharides secreted by the G033A strain and the crude exopolysaccharides secreted by the 4D19 strain could significantly improve the insecticidal activity of Vip3Aa11 against the fall armyworm within a certain dosage range, among which the crude exopolysaccharides secreted by the G033A strain improved the insecticidal activity of Vip3Aa11 against the fall armyworm more.

[0147] 3. Preparation of the second set of biological activity test solutions.

[0148] The G033A crude extracellular polysaccharide concentrate was prepared with distilled water into a biological activity test solution 28# with a final concentration of 10 mg / mL to perform a biological activity assay on the fall armyworm.

[0149] The BiotPS3 crude extracellular polysaccharide concentrate was prepared with distilled water into a biological activity test solution 29# with a final concentration of 10 mg / mL to perform biological activity assay on fall armyworm.

[0150] The BiotP4 crude extracellular polysaccharide concentrate was prepared with distilled water into a biological activity test solution 30# with a final concentration of 10 mg / mL to perform biological activity assay on fall armyworm.

[0151] Vip3Aa11 was prepared into a bioactive test solution #31 with a final concentration of 4 µg / mL using 20 mM Tris-HCl aqueous solution (pH 8.0) for bioactivity assay against Spodoptera frugiperda.

[0152] The bioactivity test solution 32# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and a final concentration of 20 mg / mL for crude G033A exopolysaccharide to carry out bioactivity assay against fall armyworm.

[0153] The bioactivity test solution 33# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 20 mg / mL for BiotPS3 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0154] The bioactivity test solution 34# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 20 mg / mL for BiotP4 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0155] The bioactivity test solution 35# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and a final concentration of 10 mg / mL for crude G033A exopolysaccharide to carry out bioactivity assay against fall armyworm.

[0156] The bioactivity test solution 36# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 10 mg / mL for BiotPS3 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0157] The bioactivity test solution 37# was prepared with 20 mM Tris-HCl aqueous solution (pH 8.0) with a final concentration of 4 µg / mL for Vip3Aa11 and 10 mg / mL for BiotP4 crude extracellular polysaccharide to carry out bioactivity assay against fall armyworm.

[0158] The biological activity assay procedure for fall armyworm was the same as in Example 5, and the results are shown in Figure 7 The results showed that the activity of crude exopolysaccharide secreted by G033A strain was similar to that of Figure 6 The results are consistent, that is, they are non-toxic to the fall armyworm when used alone, but when used in combination with Vip3Aa11, they can significantly improve the insecticidal activity of Vip3Aa11 against the fall armyworm; while the crude extracellular polysaccharides of BiotPS3 and BiotP4 are not only non-toxic to the fall armyworm alone, but also cannot improve the insecticidal activity of Vip3Aa11 against the fall armyworm after being compounded with Vip3Aa11 respectively.

[0159] Example 7: Bioassay activity analysis.

[0160] The method for preparing pure sugar of extracellular polysaccharide of G033A strain is the same as that in Example 4, wherein the medium used is liquid LB medium. The quantification of pure sugar is the same as that in Example 1.

[0161] Among them, the concentration of Cry1Ac in artificial feed was 12.5 μg / g and 25 μg / g, and the concentration of ESP-G033A in artificial feed was 2 mg / g.

[0162] The rest is the same as in Example 5, and the results are shown in Figure 8 According to the results, when the concentration of Cry1Ac was 12.5 μg / g, adding 2 mg / g of EPS-G033A significantly increased the corrected mortality rate from 25.76% to 54.54% ( p <0.01); when Cry1Ac was added to EPS-G033A at a protein concentration of 25 μg / g, the corrected mortality of larvae was significantly increased from 40.91% to 63.63% ( p <0.01).

[0163] The above results showed that the purified G033A strain extracellular polysaccharide had a good synergistic effect on the insecticidal activity of Bt Cry1Ac protein.

[0164] Example 8: Bioassay activity analysis.

[0165] The method for preparing pure sugar of extracellular polysaccharide of G033A strain is the same as that in Example 4, wherein the medium used is liquid LB medium. The quantification of pure sugar is the same as that in Example 1.

[0166] Among them, the concentration of Cry1Ac in artificial feed was 0.4 μg / g, 0.8 μg / g and 1.2 μg / g, and the concentration of ESP-G033A in artificial feed was 2 mg / g.

[0167] The rest is the same as in Example 6, and the results are shown in Fig. 9 According to the results, when the concentrations of Vip3Aa11 protein were 0.4 μg / g, 0.8 μg / g, and 1.2 μg / g, the corrected mortality rates of the larvae were 32.3%, 46.81%, and 66.01%, respectively. The addition of EPS-G033A significantly increased the corrected mortality rates to 63.06% ( p <0.01), 74.88% ( p <0.01), 86.7% ( p <0.01).

[0168] The above results showed that the purified G033A strain extracellular polysaccharide had a good synergistic effect on the insecticidal activity of Bt Vip3Aa11 protein.

[0169] Example 9: Bioassay activity analysis.

[0170] Bt G033A wettable powder (abbreviated as G033A powder) was purchased from Wuhan Kono Biotechnology Co., Ltd., and the active ingredient content was 32000 IU / mg.

[0171] The preparation method of the crude exopolysaccharide concentrate of the G033A strain is the same as that in Section 1.1 of Example 1, wherein the medium used is liquid LB medium. The quantification of the crude exopolysaccharide concentrate is the same as that in Section 1.2 of Example 1.

[0172] The steps of the bioactivity assay for fall armyworm are as follows: (1) Weigh 15 g of artificial feed ( Figure 4 ) were placed in a sterile culture dish, G033A wettable powder was mixed evenly with artificial feed at a concentration of 25, 50, 100, and 200 μg / g, and crude extracellular polysaccharide of G033A strain was mixed evenly with artificial feed at a concentration of 4 mg / mL. Wearing gloves, the feed was pressed until there were no lumps or particles, and then spread evenly in the dish; (2) Use a medicine spoon to evenly distribute the feed into a sterilized and dried 24-well culture plate, with the feed facing one side; (3) Use a brush to pick up silk threads and place newly hatched larvae of Fall Armyworm in a 24-well culture plate, one end in each well; (4) Place the 24-well culture plate in an insect culture room at a temperature of (27±1)°C, RH of (65±5)%, and a photoperiod of 16L:8D, with 3 replicates for each concentration; (5) After 7 days, count the number of dead and live worms and calculate the average mortality rate and adjusted mortality rate.

[0173] Three control groups were used: artificial diets containing crude extracellular polysaccharide of G033A strain alone, artificial diets containing wettable powder of G033A alone, and artificial diets containing neither crude extracellular polysaccharide nor wettable powder of G033A.

[0174] Results Fig.10 The results of the insecticidal activity test on fall armyworm showed that when the concentration of G033A wettable powder was 25, 50, 100, and 200 μg / g, the addition of crude extracellular polysaccharide extracts could significantly improve the insecticidal activity of G033A powder. Among them, the synergistic effect of adding crude extracellular polysaccharide extracts of G033A was the most obvious when the wettable powder concentration was 25 μg / g, which could significantly increase the corrected mortality rate from 42.89% to 76.85% (p<0.001).

[0175] The above results showed that the extracellular polysaccharide of G033A had a synergistic effect on the wettable powder of G033A, and the synergistic effect was correlated with the concentration of the wettable powder.

[0176] Example 10: Bioassay activity analysis.

[0177] The difference from Example 9 is that the biological activity test object is replaced by 1st instar cotton bollworm instead of fall armyworm. The concentration of G033A wettable powder is adjusted to 12.5, 25, and 50 μg / g; and the concentration of crude exopolysaccharide in artificial feed is still 4 mg / g.

[0178] Results Fig.11 The results of activity determination showed that when the concentration of G033A wettable powder was 12.5, 25, and 50 μg / g, the addition of crude extracellular polysaccharide extracts could significantly enhance the insecticidal activity of G033A powder. Among them, the synergistic effect of adding crude G033A sugar was the most obvious when the wettable powder concentration was 12.5 μg / g, which could significantly increase the corrected mortality rate from 49.27% ​​to 95.37% (p<0.001).

[0179] The above results indicate that G033A extracellular polysaccharide can improve the insecticidal activity of G033A wettable powder against different lepidopteran pests.

Claims

1. An extract containing extracellular polysaccharides, characterized in that It is extracted by the following steps: 1) adjusting the pH value of the fermentation broth of Bacillus thuringiensis G033A to 8 to 9, then performing a first centrifugation, and collecting a first supernatant after the first centrifugation; 2) adding trichloroacetic acid or an aqueous solution of trichloroacetic acid to the first supernatant, thereby treating the first supernatant with the trichloroacetic acid to obtain a first treated liquid, and then performing a second centrifugation to collect a second supernatant after the second centrifugation; 3) After adjusting the pH value of the second supernatant to 6 to 7, ethanol is added to the second supernatant to obtain a second treatment liquid, the second treatment liquid is precipitated, and then a third centrifugation is performed, and the precipitate after the third centrifugation is collected, and the precipitate is the wet extract containing extracellular polysaccharides.

2. The extract according to claim 1, characterized in that In step 2), the mass / volume content of the trichloroacetic acid in the first supernatant is 0.4% to 0.5%; and / or In step 3), the volume of ethanol added to the second supernatant is 3 to 3.5 times the volume of the second supernatant.

3. The extract according to claim 1, characterized in that In step 2), the first treatment solution is placed at 25 to 35° C. for 1.5 to 3 hours; and / or In step 3), the second treatment solution is placed at 2 to 8° C. for 12 to 20 hours.

4. The extract according to claim 1, characterized in that The culture medium for culturing the Bacillus thuringiensis is one of LB culture medium, a sugar-producing culture medium with glucose as a substrate, and a sugar-producing culture medium with sucrose as a substrate.

5. An extracellular polysaccharide, characterized in that It is obtained by removing residual protein, desalting, purifying by anion exchange chromatography and gel filtration chromatography from the extract according to any one of claims 1 to 4; The weight average molecular weight of the extracellular polysaccharide is 71.484 kDa, the number average molecular weight of the extracellular polysaccharide is 66.625 kDa, the average molecular weight of the extracellular polysaccharide is 76.316 kDa, the polydispersity coefficient of the extracellular polysaccharide is 1.073, and the total sugar content of the extracellular polysaccharide is 100%, mannose is 78.52%, glucose is 12.19%, arabinose is 4.41%, glucuronic acid is 3.53%, and galactose is 1.34%.

6. A composition, characterized in that The invention comprises the extract according to any one of claims 1 to 4 or the extracellular polysaccharide according to claim 5, and an active component, wherein the active component is the insecticidal crystal protein Cry1Ac derived from Bacillus thuringiensis and / or the vegetative insecticidal protein Vip3Aa derived from Bacillus thuringiensis.

7. The composition according to claim 6, characterized in that The amino acid sequence of the insecticidal crystal protein is shown in GenBank: AY730621.1; the amino acid sequence of the vegetative insecticidal protein is shown in GenBank: AAR36859.1; or The active component is the G033A strain.

8. The composition according to claim 6, characterized in that Quantifying the exopolysaccharide in the extract or the exopolysaccharide as claimed in claim 5 based on the phenol-sulfuric acid method, The mass ratio of the insecticidal crystal protein to the extracellular polysaccharide is 1:(40 to 160); and / or The mass ratio of the vegetative stage insecticidal protein to the extracellular polysaccharide is 1:(1250 to 5000).

9. The composition according to claim 7, characterized in that The G033A strain is in the form of wettable powder.

10. The composition according to claim 9, characterized in that Quantifying the exopolysaccharide in the extract or the exopolysaccharide as claimed in claim 5 based on the phenol-sulfuric acid method, The mass ratio of the wettable powder of the G033A strain to the extracellular polysaccharide is 1:(20 to 320).

11. Use of the extract according to any one of claims 1 to 4, the exopolysaccharide according to claim 5 or the composition according to any one of claims 6 to 10 in controlling fall armyworm and / or cotton bollworm.

Citation Information

Cited By

  • Application of extracellular polysaccharide or extracellular polysaccharide-containing extract in improving sunlight or ultraviolet degradation resistance of insecticidal protein

    CN119856718A

  • Application of exopolysaccharide or extract containing exopolysaccharide in enhancing insecticidal protein against sunlight or ultraviolet degradation

    CN119856718B

  • Bacillus thuringiensis for preventing and treating spodoptera frugiperda

    CN121628790A

  • A strain of Bacillus thuringiensis used to control fall armyworm

    CN121628790B